MaaT Pharma SA (EPA:MAAT)
France · Delayed Price · Currency is EUR 1.010
-0.020 (-1.94%)
Oct 2, 2026, 5:35 PM CET
MaaT Pharma Market Cap
MaaT Pharma has a market cap or net worth of €19.03 million as of October 2, 2026. Its market cap has decreased by -71.59% in one year.
Market Cap
19.03M
Enterprise Value
11.61M
Revenue
3.18M
Ranking
n/a
PE Ratio
n/a
Stock Price
€1.01
ChartMarket Cap Chart
Since November 8, 2021, MaaT Pharma's market cap has decreased from 132.73M to 19.03M, a decrease of -85.66%. That is a compound annual growth rate of -32.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 19.03M | -75.43% |
| Dec 31, 2025 | 77.47M | -29.96% |
| Dec 31, 2024 | 110.61M | 36.57% |
| Dec 29, 2023 | 80.99M | 2.32% |
| Dec 30, 2022 | 79.15M | -40.01% |
| Dec 31, 2021 | 131.95M | -0.59% |
| Nov 8, 2021 | 132.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| THX Pharma Société Anonyme | 47.05M |
| Fermentalg | 42.84M |
| Nicox | 29.96M |
| GenSight Biologics | 23.31M |
| genOway Société anonyme | 21.58M |
| Biophytis | 17.16M |
| Aelis Farma | 12.24M |
| Advicenne | 10.33M |